2020 annual financial data

Scinai Immunotherapeutics 2020 Operating margin

Scinai Immunotherapeutics 2020 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was 2,282,000 USD and net income was -1,386,000 USD.
Operating cash flow was -22,568,992 USD.

Get free Scinai Immunotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
2,282,000 USD
Net income
-1,386,000 USD
Operating cash flow
-22,568,992 USD